Identification of prognostic biomarkers for cholangiocarcinoma by combined analysis of molecular characteristics of clinical MVI subtypes and molecular subtypes.
Li MY, Liu YH, Wei F, Zhang P, Sun XD, Wang M, Du XH, Ye JF, Qiu W, Shi XJ, Ji B, Wang YC, Jiang C, Chai WG, Huang B, Liu XK, Chen QM, Fu Y, Hu XT, Chen LG, He JX, Chai KY, Gou ZM, Yang T, Wang GY, Jiang YF, Fan ZQ, Lv GY.
Li MY, et al. Among authors: liu xk.
Genomics. 2024 Sep;116(5):110889. doi: 10.1016/j.ygeno.2024.110889. Epub 2024 Jun 18.
Genomics. 2024.
PMID: 38901654
Free article.